Developing a CMS strategic plan can help align pharmaceutical supply chain objectives with overall public-sector health supply chain strategies. It can help ensure that health commodities are readily available to health facilities through an uninterrupted supply chain; minimize waste and losses; improve business and financial growth; and respond to changes in the supply chain, such as new technologies and emerging markets. In addition, advocating for and encouraging stakeholders to assess the medicine supply chain system can increase interest in generating additional technical, financial, and material resources for health care. Supply chain interventions can also contribute to improving rational medicine use and strengthening pharmaceutical regulation.
Archive | MaliRSS feed for this section
The main purpose of developing product codes for the PPM is to standardize and improve inventory management practices at the PPM, to provide input to the PPM’s product master list, and to integrate the list throughout the commodity information system. In addition, the codes will be used in the product catalogue for clients to order from.
Technical Approach to Developing a Strategic Plan to Strengthen the Central Medical Store: The Case of Pharmacie Populaire du Mali
This document describes the techniques and experiences of and lessons learned from developing a strategic plan for the Pharmacie Populaire du Mali (PPM). Technical assistance providers, managers of pharmaceutical supply chain organizations, and consultants can adapt this information to suit local contexts and needs and apply it to their own public health pharmaceutical supply chain strategic plans.
SIAPS employed a systematic and structured approach to support PPM in developing its first strategic plan, including defining the scope and refining the task of developing a strategic plan through consultation with key stakeholders; conducting a national supply chain situational analysis that included country context–political, environmental, social, legislative, economic, and ethical factors–identifying gaps between the organization’s mission and vision and the expectations of clients and stakeholders; prioritizing and developing strategic objectives; and action planning and budgeting.
The catastrophic Ebola epidemic that began in 2014 aggravated Sierra Leone’s already weak pharmaceutical supply system. The country’s pharmaceutical storage, handling, distribution, and waste disposal programs were in dire need of improvement. A “push system” of standardized medicine deliveries without reliable use data compromised inventory control and accurate forecasting, leading to frequent stock-outs or overstocks. Cost recovery also functioned poorly, potentially impacting future health care resources.
The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, implemented by Management Sciences for Health (MSH), received two years of funding in September 2015 from the US Agency for International Development (USAID) to provide technical assistance for rebuilding and strengthening the post-Ebola pharmaceuti-cal supply chain management system in Sierra Leone. SIAPS helped the country institute a continuous results monitoring and support system (CRMS) to assess baseline challenges in pharmaceutical management and regularly track and support improvement in key areas. The CRMS uses a series of indicators to track and monitor factors that influence medicine availability and disease case management. Developed in Ethiopia in 2009 to bolster malaria treatment, CRMS has proven valuable in tracking performance trends so that partners and stakeholders can come together to address service gaps.
A strong pharmaceutical management system is critical for responding to and preventing public health emergencies. The US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, implemented by Management Sciences for Health (MSH), is helping four countries affected by Ebola—Sierra Leone, Guinea, Mali, and Benin—recover and rebuild essential drug management and delivery services and to increase their capacity and sustainability. The two-year project began in 2015.
The fertility rate in Mali is high, and the rate of contraceptive use has risen gradually since 1996, reaching just over 10% in 2013. Family planning is one of the essential components of reproductive and primary health care. Download this article as a PDF The US Agency for International Development (USAID)-funded Systems for Improved Access […]
PPM is a strategic health commodities supply chain entity for the government of Mali. It operates under a performance contract with the government that is renewable every three years. The performance contract expects PPM to offer public health facilities and programs the best possible service level in terms of product availability and quality service.
Since its inception, PPM has strived to offer the best possible supply chain services, particularly procurement and distribution of health commodities, to its clients. However, while providing services, PPM has experienced a number of challenges, such as a low service level for essential health commodities, inadequate funding, and inadequate HR capacity in terms of both numbers and skills.
With an understanding of the challenges and in response to various assessments, reviews, and recommendations from stakeholders, PPM asked for technical assistance from the USAID- funded SIAPS Program to guide the best strategies to improve and strengthen PPM’s supply chain and SOPs. In response, SIAPS conducted an in-depth analysis of the current PPM operations and identified issues to be addressed, with a focus on the entire PPM supply chain system rather than just one or two areas of intervention. Among the areas assessed was the PPM MIS.
Technical Highlight: Design, Implementation, and Use of Pharmaceutical Logistics Management Information Systems (LMIS)
This technical highlight describes promising practices in assessing, designing, and implementing a LMIS based on SIAPS Program’s experience. The promising practices are supported by case examples of LMIS implementation from Bangladesh, Swaziland, and West Africa.
This report is requested by the US Agency for International Development (USAID) Mali Mission on a quarterly basis. Its purpose is to present information on progress in the implementation of activities that the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program in Mali planned for its program year (PY) 5 work plan.
The report describes achievements and related indicators, challenges, and lessons learned as well as progress in the areas of gender integration, family planning compliance activities, Ebola activities, and the environmental report.
A summary narrative on activities undertaken during the second quarter of PY5 is provided, as is an indicators table presenting the cumulative achievements to date.
During the second quarter of PY5, SIAPS supported the Ministry of Health (MOH) in implementing several activities with the aim of strengthening pharmaceutical governance, building capacity of individuals and institutions in pharmaceutical management, making logistics data available for decision making, and strengthening pharmaceutical services.
The data also suggest areas where efforts should be maintained or increased in terms of support to health facilities and services to patients through continuous coaching and supportive supervision visits.
Systems for Improved Access to Pharmaceuticals and Services: Malaria Quarterly Update – January—March 2016
Working closely with the President’s Malaria Initiative (PMI) in both Washington and PMI- focus countries, the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program aims to ensure the availability of quality pharmaceutical products and effective pharmaceutical services in support of PMI objectives. To this end, and based on the PMI’s priorities, SIAPS endeavors to improve pharmaceutical governance, build capacity to manage malaria products while addressing the information needed for managing them, strengthen financing strategies and mechanisms to improve access to malaria medicines, and improve the quality of pharmaceutical services provided to malaria patients.
The SIAPS technical approach emphasizes health systems strengthening with a special focus on improving metrics, monitoring and evaluation (M&E), developing the capacity of local governments and organizations, and increasing country ownership. Through this approach, SIAPS aims to promote the availability and use of malaria products, including artemisinin-based combination therapy (ACT), rapid diagnostic tests (RDT), and medicines for severe malaria. At the country level, SIAPS collaborates with national malaria control programs and Central Medical Stores (CMS) to develop and implement strategies to strengthen pharmaceutical management to prevent and improve case management of malaria. Areas supported by SIAPS include: training; quantification; strengthening supply chain systems, including logistics management information; community and malaria case management; rational use; and medication safety. SIAPS works to strengthen malaria pharmaceutical management at the national level in Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Guinea, Mali, Niger, and South Sudan. In addition, SIAPS provides regional support in Latin America.
This report describes the major activities that SIAPS conducted at the global level and in each of the countries and region mentioned above between January and March 2016.